239 related articles for article (PubMed ID: 29221181)
21. Mycosis fungoides in European Russia: no antibodies to human T cell leukemia virus type I structural proteins, but virus-like sequences in blood and saliva.
Morozov VA; Syrtsev AV; Ellerbrok H; Nikolaeva EV; Bavykin AS; Pauli G
Intervirology; 2005; 48(6):362-71. PubMed ID: 16024940
[TBL] [Abstract][Full Text] [Related]
22. The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome.
Liu Z; Wu X; Hwang ST; Liu J
Ann Dermatol; 2021 Dec; 33(6):487-496. PubMed ID: 34858000
[TBL] [Abstract][Full Text] [Related]
23. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients.
Pancake BA; Zucker-Franklin D; Coutavas EE
J Clin Invest; 1995 Feb; 95(2):547-54. PubMed ID: 7860737
[TBL] [Abstract][Full Text] [Related]
24. Retrospective Analysis of 118 Patients With Cutaneous T-Cell Lymphomas: A Single-Center Experience.
Polgárová K; Polívka J; Kodet O; Klener P; Trněný M
Front Oncol; 2022; 12():884091. PubMed ID: 35747818
[TBL] [Abstract][Full Text] [Related]
25. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
27. Human T-cell leukemia virus in cutaneous T-cell lymphoma in Denmark. A possible association of HTLV and aneuploidy.
Lange Wantzin G; Saxinger WC; Woods A; Larsen JK; Thomsen K; Gallo RC
Acta Derm Venereol; 1984; 64(5):395-9. PubMed ID: 6208717
[TBL] [Abstract][Full Text] [Related]
28. Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma.
Litvinov IV; Netchiporouk E; Cordeiro B; Zargham H; Pehr K; Gilbert M; Zhou Y; Moreau L; Woetmann A; Ødum N; Kupper TS; Sasseville D
Oncoimmunology; 2014 Nov; 3(11):e970025. PubMed ID: 25941598
[TBL] [Abstract][Full Text] [Related]
29. The Ectopic Expression of Meiosis Regulatory Genes in Cutaneous T-Cell Lymphomas (CTCL).
Gantchev J; Martínez Villarreal A; Xie P; Lefrançois P; Gunn S; Netchiporouk E; Sasseville D; Litvinov IV
Front Oncol; 2019; 9():429. PubMed ID: 31214493
[TBL] [Abstract][Full Text] [Related]
30. Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL).
Karenko L; Hahtola S; Ranki A
Cytogenet Genome Res; 2007; 118(2-4):353-61. PubMed ID: 18000390
[TBL] [Abstract][Full Text] [Related]
31. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
32. New
Velatooru LR; Hu CH; Bijani P; Wang X; Bojaxhi P; Chen H; Duvic M; Ni X
Cells; 2023 Sep; 12(19):. PubMed ID: 37830594
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients.
Lin WM; Lewis JM; Filler RB; Modi BG; Carlson KR; Reddy S; Thornberg A; Saksena G; Umlauf S; Oberholzer PA; Karpova M; Getz G; Mane S; Garraway LA; Dummer R; Berger CL; Edelson RL; Girardi M
J Invest Dermatol; 2012 Jan; 132(1):188-97. PubMed ID: 21881587
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate.
Mpakou V; Papadavid E; Kontsioti F; Konsta E; Vikentiou M; Spathis A; Papageorgiou S; Vasilatou D; Gkontopoulos K; Mpazani E; Karakitsos P; Rigopoulos D; Dimitriadis G; Pappa V
PLoS One; 2017; 12(1):e0170186. PubMed ID: 28107479
[TBL] [Abstract][Full Text] [Related]
35. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.
Lefrançois P; Xie P; Wang L; Tetzlaff MT; Moreau L; Watters AK; Netchiporouk E; Provost N; Gilbert M; Ni X; Sasseville D; Wheeler DA; Duvic M; Litvinov IV
Oncoimmunology; 2018; 7(8):e1467856. PubMed ID: 30221071
[TBL] [Abstract][Full Text] [Related]
37. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]